Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InnovAge Holding Corp INNV

Healthcare Drug Manufacturers - Major
InnovAge Holding Corp. is a healthcare delivery platform. It is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly (PACE... see more

Recent & Breaking News (NDAQ:INNV)

Innovus Pharmaceuticals Receives Approval for the Expanded Label Indication for its Zestra(R) Product in Canada for the Temporary Increase of Desire/Arousal in Women with Female Sexual Interest/Arousal Disorder

Accesswire October 24, 2014

Innovus Pharma Announces Podium Presentation at the World Meeting of Sexual Medicine, Discussing the Clinical Efficacy of Zestra(R) in Cancer Patients

GlobeNewswire October 2, 2014

SeeThruEquity Initiates Research Coverage on Innovus Pharmaceuticals, Inc. with a Target Price of $1.34

Accesswire September 29, 2014

Innovus Pharma Signs License Agreement With Sothema Laboratories for Zestra(R) and Zestra Glide(R) in the Middle East (Excluding Lebanon and Israel), North Africa and West Africa

GlobeNewswire September 24, 2014

Innovus Pharma Signs License Agreement With Orimed Pharma for Zestra(R), EjectDelay(TM), Sensum+(TM) and Zestra Glide(R) in Canada

GlobeNewswire September 22, 2014

Innovus Pharma Signs Exclusive Marketing Sales and Distribution Agreement With Tramorgan Limited to Market and Distribute Sensum+(TM) in the United Kingdom

GlobeNewswire September 18, 2014

SeeThruEquity Fall Microcap Investor Conference To Be Held September 11, 2014

Accesswire September 8, 2014

Innovus Pharma Expands US Distribution by Signing a Non-Exclusive Sampling and Distribution Agreement With Bulu Box(R) for Zestra(R) in the US

GlobeNewswire September 8, 2014

Innovus Pharma to Present at the 2014 Aegis Healthcare Conference in Las Vegas, NV and the See Thru Equity Fall Microcap Investor Conference in New York

GlobeNewswire September 4, 2014

Innovus Pharma Signs Exclusive Marketing and Distribution Agreement With DanaLife ApS to Market and Distribute Zestra(R) for Alternative Markets

GlobeNewswire August 28, 2014

Innovus Announces Formation of a Global Clinical Advisory Board to Support the Growth of Its Product Zestra(R)

GlobeNewswire August 21, 2014

Innovus Pharma and Consortia Health Initiate a Nationwide Marketing and Sales Campaign to U.S. Gynecologists for Zestra(R), Clinically Proven for the Enhancement of Female Arousal Desire and Satisfaction

GlobeNewswire August 15, 2014

Innovus Pharma Secures Additional Funding by Increasing Its Line of Credit With Its Chief Executive Officer to $1.5M, Provides Quarter Update and Timing of Its 10-Q Filing

GlobeNewswire August 6, 2014

Innovus Pharma to Present at the FSXinterlinked Financial Investment Conference in Westlake Village, CA

GlobeNewswire July 28, 2014

Innovus Pharma Provides Corporate Update

Accesswire June 25, 2014

Innovus Pharma to Exhibit Zestra(R), Its Clinically Proven Topical Product for Sexual Arousal and Desire at the 46th Annual Meeting of the American Association of Sexuality Educators Counselors & Therapists

GlobeNewswire June 4, 2014

Innovus Pharma Announces the Issuance of a New Canadian Patent for Its Zestra(R) Product

GlobeNewswire May 19, 2014

Innovus Pharma Announces the Beginning of Patient Enrollment in Its Post-Marketing EjectDelay(TM) Clinical Study in the Middle East

GlobeNewswire May 15, 2014

Innovus Pharma Files for the Female Sexual Interest/Arousal Disorder (FSI/AD) Expanded Label Indication for Its Zestra(R) Product in Canada

GlobeNewswire May 13, 2014

Innovus Pharma to Exhibit Zestra(R) Its Clinically Proven Product for Female Sexual Arousal and Desire at the American Congress of Obstetricians and Gynecologists 2014 Annual Meeting in Chicago

GlobeNewswire April 16, 2014